|
covid-19 |
28 |
|
sars-cov-2 |
28 |
|
receptor binding domain |
16 |
|
spike protein |
12 |
|
vaccine |
11 |
|
disease severity |
10 |
|
human neutralizing antibody |
10 |
|
linker-immunodominant site |
10 |
|
lung injury |
10 |
|
nasal turbinate |
10 |
|
phage display |
10 |
|
upper respiratory tract |
10 |
|
b-cell suppression |
8 |
|
mitochondrial dysfunction |
8 |
|
acute infection |
7 |
|
convalescent |
7 |
|
covid19 |
7 |
|
dendritic cell |
7 |
|
icu patient |
7 |
|
neutralizing antibody |
7 |
|
live-attenuated influenza-based vaccine |
6 |
|
memory t cell |
6 |
|
mitochondrial dysfunction (md) |
6 |
|
mucosal immunity |
6 |
|
nasal prevention |
6 |
|
pd1-based dna vaccine |
6 |
|
t-cell functionality |
6 |
|
ace2 expression and distribution |
5 |
|
children |
5 |
|
cytokines |
5 |
|
immunoglobulins |
5 |
|
infectious disease |
5 |
|
lung development |
5 |
|
lung progenitor cells |
5 |
|
macrophages |
5 |
|
mdscs |
5 |
|
mutation |
5 |
|
patients’ ages |
5 |
|
pulmonology |
5 |
|
sars-cov-2 virus |
5 |
|
vulnerability |
5 |
|
adult |
4 |
|
antigen spreading |
4 |
|
cd8+t cells |
4 |
|
cd8-positive t-lymphocytes - immunology - virology |
4 |
|
chimpanzee adenovirus vector |
4 |
|
china |
4 |
|
china - epidemiology |
4 |
|
crf01-ae |
4 |
|
ctls |
4 |
|
drug resistance, viral - genetics |
4 |
|
entry inhibitor |
4 |
|
epidemics |
4 |
|
female |
4 |
|
general population |
4 |
|
genes, gag |
4 |
|
genes, pol |
4 |
|
highly active antiretroviral therapy |
4 |
|
hiv |
4 |
|
hiv core protein p24 - immunology |
4 |
|
hiv infections - complications - epidemiology - virology |
4 |
|
hiv infections - prevention and control |
4 |
|
hiv-1 - classification - drug effects - genetics |
4 |
|
hiv-1 - immunology |
4 |
|
hiv-1 - pathogenicity |
4 |
|
human immunodeficiency virus |
4 |
|
humans |
4 |
|
immune response |
4 |
|
immunity |
4 |
|
immunology and microbiology section |
4 |
|
interferon-gamma - metabolism |
4 |
|
male |
4 |
|
memory cd8 t cell response |
4 |
|
mesothelioma |
4 |
|
middle aged |
4 |
|
modified vaccinia tiantan |
4 |
|
molecular epidemiology |
4 |
|
monocytes - virology |
4 |
|
persistent virus infection |
4 |
|
phylogeny |
4 |
|
pregnancy |
4 |
|
pregnancy complications, infectious - epidemiology |
4 |
|
prevalence |
4 |
|
programmed cell death 1 receptor - immunology |
4 |
|
protective immunity |
4 |
|
recombination, genetic |
4 |
|
sanguisorba officinalis |
4 |
|
sars-cov-2 vaccine |
4 |
|
sexual transmission |
4 |
|
single-dose immunization |
4 |
|
suppressor of cytokine signaling proteins - genetics |
4 |
|
t cell exhaustion |
4 |
|
traditional chinese medicine |
4 |
|
transcriptional activation |
4 |
|
vaccination |
4 |
|
virotherapy |
4 |
|
young adult |
4 |
|
amino acid motifs |
3 |
|
anti-hiv agents - chemical synthesis - pharmacology |
3 |
|
antibodies, neutralizing - genetics - immunology |
3 |
|
binding sites |
3 |
|
cells, cultured |
3 |
|
d42pd1 |
3 |
|
drug resistance, viral - drug effects |
3 |
|
drug synergism |
3 |
|
epithelial cells - virology |
3 |
|
escc |
3 |
|
genotype |
3 |
|
hiv infections - drug therapy - virology |
3 |
|
hiv reverse transcriptase - antagonists and inhibitors - genetics - metabolism |
3 |
|
hiv-1 |
3 |
|
hiv-1 - drug effects - enzymology - genetics |
3 |
|
immunity, mucosal - immunology |
3 |
|
immunohistochemistry |
3 |
|
leukocytes, mononuclear - drug effects - virology |
3 |
|
microbial sensitivity tests |
3 |
|
models, molecular |
3 |
|
monoclonal antibody |
3 |
|
nevirapine - pharmacology |
3 |
|
pd1 |
3 |
|
pyranocoumarins - chemical synthesis - pharmacology |
3 |
|
reverse transcriptase inhibitors - chemical synthesis - pharmacology |
3 |
|
salivary ducts - virology |
3 |
|
sars virus - isolation and purification - pathogenicity |
3 |
|
severe acute respiratory syndrome - veterinary - virology |
3 |
|
smallpox vaccine - administration and dosage - immunology |
3 |
|
tumor |
3 |
|
vaccinia - immunology - prevention and control |
3 |
|
vaccinia virus - genetics - immunology |
3 |
|
virus replication - drug effects |
3 |
|
ace2 |
2 |
|
adcc |
2 |
|
aids |
2 |
|
aids (艾滋病) |
2 |
|
allergology and immunology |
2 |
|
animal model |
2 |
|
animals |
2 |
|
anti-hiv agents - chemical synthesis - chemistry - pharmacology |
2 |
|
antibodies, viral - chemistry |
2 |
|
apoptosis |
2 |
|
cannabinoids |
2 |
|
ccr7 |
2 |
|
cd4 t cells |
2 |
|
cd4-induced |
2 |
|
cell biology |
2 |
|
cell culture |
2 |
|
cell isolation |
2 |
|
cell line |
2 |
|
central memory cd4 t cells |
2 |
|
chinese macaques |
2 |
|
chinese rhesus monkey |
2 |
|
chromones - chemical synthesis - chemistry - pharmacology |
2 |
|
combinatorial chemistry techniques |
2 |
|
communicable diseases medical sciences |
2 |
|
coumarins - chemical synthesis - chemistry - pharmacology |
2 |
|
crf01_ae |
2 |
|
crf07_bc |
2 |
|
disease models, animal |
2 |
|
dna methylation |
2 |
|
drug resistance |
2 |
|
effector/effector memory cd4 t cells |
2 |
|
fujian |
2 |
|
gene deletion |
2 |
|
gene expression |
2 |
|
genes, viral |
2 |
|
genetic vectors |
2 |
|
genome |
2 |
|
green fluorescent proteins - genetics |
2 |
|
gut-homing t cell |
2 |
|
haart |
2 |
|
hand |
2 |
|
hela cells |
2 |
|
hiv infection |
2 |
|
hiv infections - drug therapy - genetics |
2 |
|
hiv-1 - drug effects |
2 |
|
hiv-1 - drug effects - genetics |
2 |
|
hiv-1 - genetics |
2 |
|
hiv-1 latent infection |
2 |
|
ige+b cell |
2 |
|
immunology |
2 |
|
lung pathogenesis |
2 |
|
macaca mulatta - virology |
2 |
|
medical sciences |
2 |
|
mice |
2 |
|
mice, inbred balb c |
2 |
|
microscopy |
2 |
|
msm |
2 |
|
mutagenesis |
2 |
|
mvtt |
2 |
|
nsg |
2 |
|
peptidyl-dipeptidase a - chemistry - genetics - metabolism |
2 |
|
pyranocoumarins - chemical synthesis - chemistry - pharmacology |
2 |
|
rabbits |
2 |
|
receptors, ccr5 - physiology |
2 |
|
receptors, virus - physiology |
2 |
|
recombinant fusion proteins |
2 |
|
rhesus macaque |
2 |
|
sars |
2 |
|
sars virus - physiology |
2 |
|
sars-cov |
2 |
|
severe acute respiratory syndrome - enzymology - pathology - virology |
2 |
|
shiv |
2 |
|
simian acquired immunodeficiency syndrome - virology |
2 |
|
siv |
2 |
|
stereoisomerism |
2 |
|
structure-activity relationship |
2 |
|
subtype b' |
2 |
|
th1 |
2 |
|
th17 |
2 |
|
thc |
2 |
|
transmitted/founder |
2 |
|
treg |
2 |
|
v2 |
2 |
|
vaccine (疫苗) |
2 |
|
vaccinia |
2 |
|
vaccinia (痘苗) |
2 |
|
vaccinia tian tan |
2 |
|
vaccinia tiantan (天坛痘苗) |
2 |
|
vaccinia virus - genetics |
2 |
|
vaccinia virus - genetics - immunology - pathogenicity - physiology |
2 |
|
viral vaccines - genetics - immunology - metabolism |
2 |
|
viral vector |
2 |
|
viral vector (病毒载体) |
2 |
|
virus internalization |
2 |
|
virus replication |
2 |
|
virus replication - drug effects - genetics |
2 |
|
b‐lymphocyte |
1 |
|
immortalized |
1 |
|
nhl |
1 |
|
spontaneous |
1 |
